FOXO updates shareholders on 2024 achievements and future plans
coverager - Nov 19, 2024
FOXO began 2024 with a continued focus on commercializing its epigenetic technology....
Recommended Articles
Posted: Sep 12, 2025
The appointments follow the promotion of Dan Byrne to Chief Commercial Officer....
Posted: Sep 12, 2025
The collaboration is positioned as a tool for retention at a time when student debt remains a major...
Posted: Sep 12, 2025
Available through AXA’s Digital Commercial Platform....